Taikang Wu

Papers

Total Citations

H-Index

About

Taikang Wu is a rising researcher at the forefront of nanomedicine and bioinspired micro/nanorobotics. His work focuses on overcoming critical barriers in enzyme-powered micro/nanomotors (MNMs) for cancer therapy, particularly addressing the challenge of rapid deactivation in hostile tumor microenvironments. Wu’s most notable contribution is the design of anti-biopassivated reticular micromotors, which leverage hydrogen bond-rich metal-organic frameworks (MOFs) to protect urease engines from biofouling. This innovation, detailed in his highly cited 2025 paper (10 citations), significantly extends the operational lifespan of these micromotors, enabling sustained propulsion and targeted drug delivery for bladder cancer treatment. By integrating MOF chemistry with active motility, Wu’s work bridges materials science and oncology, offering a robust platform for next-generation therapeutic microrobots. His research has already garnered attention for its potential to transform localized cancer therapy, marking him as a key contributor to the evolving field of biomedical microdevices.